<?xml version="1.0" encoding="UTF-8"?>
<p id="p0110">In consideration of the central role that interleukin-6, in combination with other proinflammatory cytokines, seems to have in the development of the cytokine release syndrome,
 <xref rid="bib17" ref-type="bibr">
  <sup>17</sup>
 </xref> tocilizumab could play a role in the management of selected cases in the absence of major contraindications.
</p>
